Biocartis Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 18 shareholders own 37.79% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.1%	Invesco Ltd.	6,963,025	€8.3m	0%	no data
9.5%	Johnson & Johnson Innovation - JJDC, Inc.	5,466,838	€6.5m	0%	1.57%
3.9%	Participatiemaatschappij Vlaanderen NV	2,244,281	€2.7m	0%	4.55%
3.68%	Credit Suisse, Investment Banking and Securities Investments	2,115,532	€2.5m	0%	no data
3.67%	Credit Suisse Asset Management (Switzerland)	2,112,084	€2.5m	0%	no data
1.53%	Mirova US LLC	882,561	€1.0m	-11.7%	0.02%
0.9%	KBC Asset Management NV	516,061	€612.9k	0%	no data
0.77%	Sycomore Asset Management SA	445,319	€528.9k	0%	0.02%
0.59%	BNPP Asset Management Holding	340,514	€404.4k	0%	no data
0.51%	Dimensional Fund Advisors LP	292,937	€347.9k	0.34%	no data
0.21%	Causeway Capital Management LLC	119,513	€141.9k	0%	no data
0.2%	Schroder Investment Management North America Inc.	113,425	€134.7k	0%	no data
0.13%	J.P. Morgan Asset Management, Inc.	72,517	€86.1k	0%	no data
0.046%	Baillie Gifford & Co.	26,628	€31.6k	0%	no data
0.026%	NN Investment Partners Holdings N.V.	15,000	€17.8k	200%	no data
0.017%	Capfi Delen Asset Management NV	10,000	€11.9k	0%	no data
0.017%	Stevens & Et De Munter S.A., Asset Management Arm	10,000	€11.9k	0%	0.08%
0.0015%	State Street Global Advisors, Inc.	872	€1.0k	-95.8%	no data